Kilter Group’s Avanos Medical AVNS Stock Holding History

Kilter Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175	Hold	7	–	–	﹤0.01%	1503
2026 Q1	$99	Buy	+7	New	+$94	﹤0.01%	1516

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Kilter Group's AVNS Position: Q2 2026 in Review

Kilter Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 7 shares worth $175. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Kilter Group first reported a position in AVNS in Q1 2026 and has held it in 2 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Kilter Group held 7 shares of Avanos Medical worth $175 as of Q2 2026.
Kilter Group left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1503 holding.
Kilter Group first reported a position in Avanos Medical in Q1 2026 and has held it in 2 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.